Researchers have identified cellular factors that regulate the delivery and stability of mRNA to expand the potential of mRNA therapeutics.

Focused government troubleshooting to improve the investment landscape is paving the way for billions of additional US dollars across a range of industries.

Video presentation of Damien Perriman available here.

In this week’s edition of InnovationRx, we look at Trump's massive health agency layoffs, Palantir’s trade secret lawsuit, ...

“I am pleased to welcome Teresa to our Board of Directors,” said Elisabet de los Pinos, Chief Executive Officer of Aura Biosciences. “She is a seasoned leader whose extensive operational and ...

Data center construction has been met with some apprehension, including the low number of jobs produced for the large tax ...

National Laboratory is taking a giant leap in fostering new space innovators with the launch of the Orbital Edge ...

New construction in the Huntsville area topped $509.7 million in the first quarter of 2025, according to building permits ...

Biology — the science of life, living things and the processes that keep us all running — links up in essential ways with ...

Penza Oblast of Russia offers Belarus cooperation in biotechnology, agriculture, machinery supplies, and also in the implementation of cultural projects, Governor of Russia’s Penza Oblast Oleg ...

Radnor, Pennsylvania-based Mineralys is a clinical-stage biopharmaceutical company developing treatments for hypertension, ...

Professors Joshua Leonard and Jonathan Rivnay are part of AIMBE’s College of Fellows Class of 2025, among the highest ...